Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: J Rheumatol. 2018 May 1;45(9):1308–1315. doi: 10.3899/jrheum.170928

Figure 1.

Figure 1

Sensitivity to Change of Single Pain-Related Outcomes from the Tanezumab Trial. Values plotted are the control-treatment differences in standard score, at different study time points. More negative values indicate increased sensitivity to change